| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb26d26692dd30f95fcb3f0c12b9ecd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a0296de83b6b3194be4ca7c881fbc0b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
1999-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14e71f3caaad7e68f39060c0f4e6cfe0 |
| publicationDate |
2000-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0013691-A2 |
| titleOfInvention |
3-deazaadenosine prevents atherosclerosis and graft vasculopathy |
| abstract |
The invention relates to the use of 3-deazaadenosine and analogs thereof for the manufacture of a medicament against vascular diesases or graft rejection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7306950-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8187333-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9393126-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02094248-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8814937-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02094248-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9364339-B2 |
| priorityDate |
1998-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |